Shagun Singh Chadha
Stock Analyst at RBC Capital
(0.72)
# 4,061
Out of 4,579 analysts
664
Total ratings
44.1%
Success rate
-1.3%
Average return
Main Sectors:
Stocks Rated by Shagun Singh Chadha
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Reiterated: Buy | $110 | $83.04 | +32.47% | 54 | Jul 23, 2026 | |
| GEHC GE HealthCare Technologies | Reiterated: Buy | $80 | $61.12 | +30.89% | 3 | Jul 23, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $130 | $104.49 | +24.41% | 44 | Jul 16, 2026 | |
| ISRG Intuitive Surgical | Maintained: Buy | $600 → $575 | $356.83 | +61.14% | 48 | Jul 16, 2026 | |
| BDX Becton, Dickinson and Company | Maintained: Hold | $175 | $158.92 | +10.12% | 12 | Jul 13, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $100 → $85 | $45.51 | +86.77% | 57 | Jul 13, 2026 | |
| DXCM DexCom | Maintained: Buy | $85 | $73.37 | +15.85% | 28 | Jul 13, 2026 | |
| PODD Insulet | Maintained: Buy | $280 → $245 | $165.00 | +48.48% | 18 | Jul 13, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $265 → $287 | $265.95 | +7.92% | 46 | Jul 13, 2026 | |
| MDT Medtronic | Maintained: Buy | $118 | $84.22 | +40.11% | 47 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $435 | $336.74 | +29.18% | 47 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $155 | $131.05 | +18.28% | 51 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $92.07 | +9.70% | 41 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $115 | $78.25 | +46.96% | 40 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $17.17 | +74.72% | 20 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $374 | $319.49 | +17.06% | 39 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 | $50.93 | -11.64% | 28 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 | $4.32 | +62.04% | 40 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $74 | $19.53 | n/a | 1 | Apr 29, 2021 |
Edwards Lifesciences
Jul 23, 2026
Reiterated: Buy
Price Target: $110
Current: $83.04
Upside: +32.47%
GE HealthCare Technologies
Jul 23, 2026
Reiterated: Buy
Price Target: $80
Current: $61.12
Upside: +30.89%
Abbott Laboratories
Jul 16, 2026
Reiterated: Buy
Price Target: $130
Current: $104.49
Upside: +24.41%
Intuitive Surgical
Jul 16, 2026
Maintained: Buy
Price Target: $600 → $575
Current: $356.83
Upside: +61.14%
Becton, Dickinson and Company
Jul 13, 2026
Maintained: Hold
Price Target: $175
Current: $158.92
Upside: +10.12%
Boston Scientific
Jul 13, 2026
Maintained: Buy
Price Target: $100 → $85
Current: $45.51
Upside: +86.77%
DexCom
Jul 13, 2026
Maintained: Buy
Price Target: $85
Current: $73.37
Upside: +15.85%
Insulet
Jul 13, 2026
Maintained: Buy
Price Target: $280 → $245
Current: $165.00
Upside: +48.48%
Johnson & Johnson
Jul 13, 2026
Maintained: Buy
Price Target: $265 → $287
Current: $265.95
Upside: +7.92%
Medtronic
Jul 13, 2026
Maintained: Buy
Price Target: $118
Current: $84.22
Upside: +40.11%
Jul 13, 2026
Maintained: Buy
Price Target: $435
Current: $336.74
Upside: +29.18%
Jul 13, 2026
Maintained: Buy
Price Target: $155
Current: $131.05
Upside: +18.28%
Jul 13, 2026
Maintained: Buy
Price Target: $101
Current: $92.07
Upside: +9.70%
Jul 13, 2026
Maintained: Buy
Price Target: $120 → $115
Current: $78.25
Upside: +46.96%
Jul 13, 2026
Maintained: Buy
Price Target: $30
Current: $17.17
Upside: +74.72%
Jul 13, 2026
Maintained: Hold
Price Target: $374
Current: $319.49
Upside: +17.06%
Jul 13, 2026
Maintained: Hold
Price Target: $45
Current: $50.93
Upside: -11.64%
Jul 13, 2026
Maintained: Hold
Price Target: $7
Current: $4.32
Upside: +62.04%
Apr 29, 2021
Maintained: Hold
Price Target: $74
Current: $19.53
Upside: n/a